awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37307819-0DE4F80B-6839-49A7-BFFF-C19128EE740B
Q37307819-0DE4F80B-6839-49A7-BFFF-C19128EE740B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37307819-0DE4F80B-6839-49A7-BFFF-C19128EE740B
Bevacizumab in the treatment of HER2-negative breast cancer.
P2860
Q37307819-0DE4F80B-6839-49A7-BFFF-C19128EE740B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37307819-0DE4F80B-6839-49A7-BFFF-C19128EE740B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a3fcf01ecd7a63842ff70e18be3c2a5ad8b1ea9
P2860
Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.